Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AngioDynamics is a global medical technology company that designs, manufactures, and sells a wide range of minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology. The company significantly expanded its presence in the venous treatment market through the 2008 acquisition of Diomed, a pioneer in Endovenous Laser Treatment (EVLT). Today, the "Diomed Direct" brand serves as a dedicated commercial portal for the VenaCure EVLT product line, providing laser systems, specialized fibers, and procedure kits for the treatment of varicose veins. AngioDynamics' broader portfolio includes innovative technologies such as the NanoKnife System for tissue ablation and the Auryon laser system for peripheral artery disease. The company is headquartered in Latham, New York, and is publicly traded on the NASDAQ exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diomed Direct.